TrialStem cell research & therapy2017
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.
Atieh Makhlough et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papertrialcites it